All PlansAdministrativeMedium impact
Voluntary nationwide recall: Vancomycin (Amneal - March)
UPMC Health Plan·Pharmacy, Infectious Disease, Internal Medicine +2 more·Pharmacy
Effective date
Mar 27, 2024
We identified it
Aug 7, 2026
Summary
Amneal Pharmaceuticals is recalling four lots of Vancomycin Hydrochloride for Oral Solution (250 mg/5 mL) due to potential overfilling that may result in higher doses and increased risk of adverse effects including kidney damage. Billing teams must be aware that patients may return or discontinue this medication, which could affect claims processing and patient billing for affected prescriptions.
Action Required
Immediately: Billing and clinical teams should coordinate to identify any claims submitted for the recalled Amneal Vancomycin lots (contact Amneal at 1-833-582-0812 or visit FDA website for specific lot numbers). Flag affected patient accounts and be prepared to process adjustments, refunds, or claim corrections if patients return medication or discontinue use. Update patient communications if applicable. No changes to billing codes or procedures are required; this is a medication safety alert requiring administrative awareness and potential claim reconciliation.